Senti Biosciences, Inc. (SNTI)
(Real Time Quote from BATS)
$1.71 USD
-0.03 (-1.72%)
Updated Aug 5, 2025 03:02 PM ET
3-Hold of 5 3
F Value D Growth D Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, Senti Biosciences, Inc. has a market cap of $45.38M, which represents its share price of $1.74 multiplied by its outstanding shares number of 26.08M. As a small-cap company, SNTI's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
SNTI 1.71 -0.03(-1.72%)
Will SNTI be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for SNTI based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for SNTI
SNTI Stock Skyrockets on Initial Data From Phase I Cancer Study
SNTI: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for SNTI
SNTI Advances SENTI-202 to Phase 2 Dosage in Ongoing Clinical Study
Senti Bio Determines Recommended Phase 2 Dose (RP2D) in Phase 1 Study of SENTI-202 for the ...
Senti Bio confirms recommended RP2D in Phase 1 study of SENTI-202
Senti Bio's Chief Medical Officer, Kanya Rajangam, M.D., Ph.D. ...